Literature DB >> 2562925

Laboratory diagnosis of the first cases of HIV-2 infection in Canada.

P W Neumann1, M V O'Shaughnessy, D Lepine, I D'Souza, C Major, B McLaughlin.   

Abstract

Until recently the geographic distribution of infection due to human immunodeficiency virus type 2 (HIV-2) had excluded North America. We report the first two cases of such infection in Canada. Both people came from endemic areas of western Africa and were asymptomatic. The results of a commercial enzyme immunoassay specific for HIV-1 antibody were positive in both cases, but those of the Western blot technique were indeterminate. The Western blot technique specific for HIV-2 antibody and the indirect fluorescent antibody test were used to verify the presence of HIV-2 antibody.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2562925      PMCID： PMC1268581     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


  7 in total

1.  Isolation of a new human retrovirus from West African patients with AIDS.

Authors:  F Clavel; D Guétard; F Brun-Vézinet; S Chamaret; M A Rey; M O Santos-Ferreira; A G Laurent; C Dauguet; C Katlama; C Rouzioux
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

2.  Patterns of antibody response in individuals infected with the human immunodeficiency virus.

Authors:  L Z Pan; C Cheng-Mayer; J A Levy
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

3.  The global distribution of human immunodeficiency virus type 2 (HIV-2) infection.

Authors:  C R Horsburgh; S D Holmberg
Journal:  Transfusion       Date:  1988 Mar-Apr       Impact factor: 3.157

4.  Human immunodeficiency virus type 2 infection associated with AIDS in West Africa.

Authors:  F Clavel; K Mansinho; S Chamaret; D Guetard; V Favier; J Nina; M O Santos-Ferreira; J L Champalimaud; L Montagnier
Journal:  N Engl J Med       Date:  1987-05-07       Impact factor: 91.245

5.  HTLV-III infection in Canada in 1985.

Authors:  P W Neumann; B J Benning; D G Robinson; N Gilmore; M V O'Shaughnessy
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

6.  Comparison of 10 enzyme immunoassays for detection of antibody to human immunodeficiency virus type 2 in West African sera.

Authors:  F Denis; G Leonard; A Sangare; G Gershy-Damet; J L Rey; B Soro; D Schmidt; M Mounier; M Verdier; A Baillou
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

7.  Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2).

Authors:  R G Marlink; D Ricard; S M'Boup; P J Kanki; J L Romet-Lemonne; I N'Doye; K Diop; M A Simpson; F Greco; M J Chou
Journal:  AIDS Res Hum Retroviruses       Date:  1988-04       Impact factor: 2.205
  7 in total
  7 in total

1.  Use of quantitative HIV RNA detection for early diagnosis of HIV infection in infants and acute HIV infections in Alberta, Canada.

Authors:  Bonita E Lee; Sabrina S Plitt; Gayatri C Jayaraman; Linda Chui; Ameeta E Singh; Jutta K Preiksaitis
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.

Authors:  B Böttiger; A Karlsson; P A Andreasson; A Nauclér; C M Costa; E Norrby; G Biberfeld
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

3.  HIV infection among Quebec women giving birth to live infants.

Authors:  C A Hankins; C Laberge; N Lapointe; M T Lai Tung; L Racine; M O'Shaughnessy
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

4.  Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Authors:  Nuno R Faria; Ioannis Hodges-Mameletzis; Joana C Silva; Berta Rodés; Smit Erasmus; Stefania Paolucci; Jean Ruelle; Danuta Pieniazek; Nuno Taveira; Ana Treviño; Maria F Gonçalves; Sabelle Jallow; Li Xu; Ricardo J Camacho; Vincent Soriano; Patrick Goubau; João D de Sousa; Anne-Mieke Vandamme; Marc A Suchard; Philippe Lemey
Journal:  J Gen Virol       Date:  2011-12-21       Impact factor: 3.891

5.  Differential regulation of human immunodeficiency viruses (HIVs): a specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor.

Authors:  D M Markovitz; M Hannibal; V L Perez; C Gauntt; T M Folks; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  First documented case of human immunodeficiency virus type 2 infection in an asymptomatic Swiss subject.

Authors:  P Bürgisser; L Odier; J Schüpbach; P C Frei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

7.  Performance characteristics of recombinant enzyme immunoassay to detect antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 and to measure early antibody responses in seroconverting patients.

Authors:  R A Galli; S Castriciano; M Fearon; C Major; K W Choi; J Mahony; M Chernesky
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.